Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TLX1/HOX11-induced hematopoietic differentiation blockade.

I Riz1, S S Akimov, S S Eaker

  • 1Department of Anatomy and Cell Biology, The George Washington University Medical Center, Washington, DC 20037, USA.

Oncogene
|January 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overdispersion models for correlated multinomial data: Applications to blinding assessment.

Statistics in medicine·2019
Same author

Dataset of Arabidopsis plants that overexpress FT driven by a meristem-specific KNAT1 promoter.

Data in brief·2016
Same author

Transcriptomic analysis of Arabidopsis overexpressing flowering locus T driven by a meristem-specific promoter that induces early flowering.

Gene·2016
Same author

Transposable elements donate lineage-specific regulatory sequences to host genomes.

Cytogenetic and genome research·2005
Same author

PROSPECT improves cis-acting regulatory element prediction by integrating expression profile data with consensus pattern searches.

Nucleic acids research·2001
Same author

Curved DNA in promoter sequences.

In silico biology·2001

The proto-oncogene TLX1/HOX11 blocks blood cell development. Researchers found TLX1/HOX11 directly binds to CBP, a protein crucial for differentiation, potentially sequestering it in repressive chromatin to halt erythroid development.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Aberrant expression of the human homeobox-containing proto-oncogene TLX1/HOX11 is implicated in inhibiting hematopoietic differentiation.
  • Understanding the molecular mechanisms underlying TLX1/HOX11-mediated differentiation arrest is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of TLX1/HOX11 in regulating erythroid differentiation.
  • To elucidate the interaction between TLX1/HOX11 and CREB-binding protein (CBP) during erythropoiesis.

Main Methods:

  • Establishment of a murine erythroid progenitor cell line (iEBHX1S-4) with regulatable TLX1 expression.
  • Analysis of erythroid marker acquisition and hemoglobin synthesis upon TLX1 downregulation.
  • Bioinformatic analysis, co-immunoprecipitation, glutathione-S-transferase pull-down assays, and confocal laser microscopy to study protein interactions and localization.

Related Experiment Videos

Main Results:

  • TLX1/HOX11 expression caused developmental arrest in erythroid progenitors.
  • Downregulation of TLX1/HOX11 restored erythropoietin-dependent differentiation and hemoglobin synthesis.
  • TLX1/HOX11 directly binds to CBP, and this interaction influences CBP localization within the nucleus, including repressive chromatin domains.

Conclusions:

  • TLX1/HOX11 inhibits erythroid differentiation by directly interacting with CBP.
  • TLX1/HOX11 may sequester CBP in repressive chromatin, thereby blocking transcriptional networks essential for erythropoiesis.
  • These findings provide insights into the molecular mechanisms of oncogene-induced differentiation arrest.